epirubicin has been researched along with Fibrous Tissue Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Muderis, O; Constantinidou, A; Fisher, C; Jones, RL; Judson, I; Olmos, D; Thway, K | 1 |
1 other study(ies) available for epirubicin and Fibrous Tissue Neoplasms
| Article | Year |
|---|---|
Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neoplasms, Fibrous Tissue; Prognosis; Retrospective Studies; Survival Rate | 2012 |